363 related articles for article (PubMed ID: 1445269)
1. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
2. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W
Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341
[TBL] [Abstract][Full Text] [Related]
3. The active site of human C4a anaphylatoxin.
Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
[TBL] [Abstract][Full Text] [Related]
4. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
5. The pharmacophore of the human C5a anaphylatoxin.
Toth MJ; Huwyler L; Boyar WC; Braunwalder AF; Yarwood D; Hadala J; Haston WO; Sills MA; Seligmann B; Galakatos N
Protein Sci; 1994 Aug; 3(8):1159-68. PubMed ID: 7987211
[TBL] [Abstract][Full Text] [Related]
6. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
9. In Xenopus oocytes the human C3a and C5a receptors elicit a promiscuous response to the anaphylatoxins.
Ames RS; Nuthulaganti P; Kumar C
FEBS Lett; 1996 Oct; 395(2-3):157-9. PubMed ID: 8898085
[TBL] [Abstract][Full Text] [Related]
10. Active site of C3a anaphylatoxin: contributions of the lipophilic and orienting residues.
Unson CG; Erickson BW; Hugli TE
Biochemistry; 1984 Feb; 23(4):585-9. PubMed ID: 6608957
[TBL] [Abstract][Full Text] [Related]
11. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
Cain SA; Monk PN
J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
[TBL] [Abstract][Full Text] [Related]
12. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
[TBL] [Abstract][Full Text] [Related]
13. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
[TBL] [Abstract][Full Text] [Related]
14. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
[TBL] [Abstract][Full Text] [Related]
15. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
[TBL] [Abstract][Full Text] [Related]
16. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
Gerard C; Hugli TE
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
[TBL] [Abstract][Full Text] [Related]
17. Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg.
Bajic G; Yatime L; Klos A; Andersen GR
Protein Sci; 2013 Feb; 22(2):204-12. PubMed ID: 23184394
[TBL] [Abstract][Full Text] [Related]
18. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
Marceau F; Hugli TE
J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
[TBL] [Abstract][Full Text] [Related]
19. Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor.
Carney DF; Hugli TE
Protein Sci; 1993 Sep; 2(9):1391-9. PubMed ID: 8401225
[TBL] [Abstract][Full Text] [Related]
20. Effects of human anaphylatoxins on guinea pig atria.
Huey R; Bloor CM; Hugli TE
Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]